Old National Bancorp’s Myriad Genetics MYGN Stock Holding History

Old National Bancorp’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-7,053	Closed	-$275K	–	571
2014 Q2	$275K	Hold	7,053	–	–	0.02%	445
2014 Q1	$241K	Buy	+7,053	New	+$219K	0.02%	380

Other funds holding MYGN

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Old National Bancorp's MYGN Position: Q3 2014 in Review

Old National Bancorp sold out of Myriad Genetics (MYGN) in Q3 2014, closing a stake of 7,053 shares — an estimated $275K sold.

Old National Bancorp first reported a position in MYGN in Q1 2014 and held it in 2 quarters. The position peaked at $275K in Q2 2014. 275 funds tracked by Wall St. Rank hold MYGN as of Q3 2014.

Old National Bancorp reported no remaining Myriad Genetics position as of Q3 2014 after selling out during the quarter.
Old National Bancorp sold 7,053 Myriad Genetics shares in Q3 2014, an estimated $275K.
Old National Bancorp first reported a position in Myriad Genetics in Q1 2014 and held it in 2 quarters.
Old National Bancorp's Myriad Genetics position peaked at $275K in Q2 2014.
275 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2014.

Based on Old National Bancorp's 13F filing for Q3 2014, filed 17 Nov 2014.